KERA's Think The surprising new science of A.D.H.D.
10 snips
May 14, 2025 
Paul Tough, a contributing writer for The New York Times Magazine, dives into the evolving understanding of A.D.H.D. He argues that many may experience symptoms temporarily, challenging the idea of permanent diagnoses. Tough discusses the biases in diagnosing A.D.H.D., particularly in women, and why traditional stimulant medications are under scrutiny. He highlights how educational environments impact concentration and the need for more personalized learning solutions. Ultimately, Tough champions a more nuanced approach to treatment that prioritizes individual experiences.
AI Snips
Chapters
Transcript
Episode notes
ADHD Diagnosis Challenges
- ADHD diagnosis relies on a set of symptoms present in multiple settings for at least six months.
- Diagnosis involves subjective clinical assessments despite precise DSM criteria.
How Stimulants Aid Focus
- Stimulant medications like Ritalin improve focus and behavior in most with ADHD.
- They help patients concentrate better by making distractions less compelling and engaging monotonous tasks.
Stimulants Affect Everyone Similarly
- Stimulant medications affect focus and behavior similarly in people with or without ADHD.
- The idea that only those with ADHD benefit from stimulants is a misconception.